StopAfib interviews Dr. James Reiffel Find a transcript and more on Dr. Reiffel at: www.stopafib.org In this video interview at Heart Rhythm 2012, Dr. James Reiffel updates us on new directions in drug treatments for atrial fibrillation. He talks about the combination of ranolazine (Ranexa) and dronedarone (Multaq), both used …
Read More
At Heart Rhythm 2012, Dr. James Reiffel gave us an update on new medications for treating atrial fibrillation, including the combination of low doses of ranolazine (Ranexa) and dronedarone (Multaq). He also talked about rate control vs. rhythm control for afib, and how the decision can vary by age and level of symptoms. Watch the …
Read More
The Atrial Fibrillation Optimal Treatment Task Force, led by the Alliance for Aging Research, has just released a consensus statement developed by a group of leading afib stroke prevention experts. We at StopAfib.org are proud to have been part of the development of this consensus statement, which recommends a process for assessing afib stroke and …
Read More
StopAfib.org interviews Dr. Eric Prystowsky of St. Vincent's Hospital in Indianapolis, Indiana Find more on Dr. Prystowsky: www.stopafib.org Find more on rate control for the treatment of afib at: www.stopafib.org In this video, Dr. Prystowsky discussed the proper application of rate control as a method of controlling atrial fibrillation, as …
Read More
In this video interview recorded at Heart Rhythm 2012, Dr. Eric Prystowsky tackled the controversial topic of rate control vs. rhythm control for treating atrial fibrillation, and knowing whether you are symptomatic or asymptomatic. He also discussed the issues related to leaving afib patients on rate control long term, such as the buildup of fibrosis …
Read More
The June issue of EP Lab Digest featured an interview with StopAfib.org founder Mellanie True Hills about the recent launch of the Global Atrial Fibrillation Patient Charter and the Sign Against Stroke in Atrial Fibrillation Campaign at the World Congress of Cardiology in Dubai. The Global AF Patient Charter focused on five critical recommendations that could …
Read More
At Heart Rhythm 2012, Dr. Albert Waldo shared with StopAfib.org’s Mellanie True Hills about why aspirin should no longer be used for the prevention of stroke in atrial fibrillation. Dr. Waldo noted that many global afib guidelines have been revised, or soon will be, to remove aspirin as a recommended atrial fibrillation stroke prevention treatment. …
Read More
StopAfib.org interviews Dr. Albert Waldo of Case Western Reserve University Find more information on this topic, and Dr. Waldo, at: www.stopafib.org In this video interview at Heart Rhythm 2012, Dr. Albert Waldo, one of the world's foremost atrial fibrillation treatment experts, discusses why aspirin no longer plays a role in …
Read More
At Heart Rhythm 2012, Dr. Sanjiv Narayan gave us an update on his FIRM (focal impulse and rotor modulation) ablation research, including that other centers have been duplicating his work in ablating rotors and focal beats. Amazingly, some patients have had their atrial fibrillation wiped out in a matter of minutes. Watch the video or …
Read More
StopAfib.org interviews Dr. Sanjiv Narayan of the University of California, San Diego Find more information on this topic, and Dr. Narayan, at: www.stopafib.org In this video interview at Heart Rhythm 2012, Dr. Sanjiv Narayan updates us on the progress of his FIRM (focal impulse and rotor modulation) ablation research and …
Read More